Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents.
Read More…
Industry, Sector and Symbol
Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+49-214-301
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees111,015
Next Earnings DateN/A
OptionableNot Optionable
Bayer (FRA:BAYN) Frequently Asked Questions
What is Bayer's stock symbol?
Bayer trades on the FRA under the ticker symbol "BAYN."
What price target have analysts set for BAYN?
18 brokers have issued 1 year price targets for Bayer's shares. Their forecasts range from €61.00 to €123.00. On average, they expect Bayer's stock price to reach €78.47 in the next year. This suggests a possible upside of 13.8% from the stock's current price. View Analyst Price Targets for Bayer.
What is the consensus analysts' recommendation for Bayer?
18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bayer in the last year. There are currently 1 sell rating, 9 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Bayer.
Has Bayer been receiving favorable news coverage?
News coverage about BAYN stock has trended somewhat positive this week, according to InfoTrie Sentiment. The research firm ranks the sentiment of press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Bayer earned a media sentiment score of 0.9 on InfoTrie's scale. They also gave news stories about the healthcare company a news buzz of 1.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for Bayer.
Who are some of Bayer's key competitors?
What other stocks do shareholders of Bayer own?
Who are Bayer's key executives?
Bayer's management team includes the folowing people:
- Mr. Werner Baumann, Chairman of Management & CEO (Age 57)
- Mr. Wolfgang U. Nickl, CFO & Member of Management Board (Age 50)
- Mr. Liam Condon, Pres of Bayer Crop Science Division & Member of Management Board (Age 51)
- Dr. Kemal Malik, Head of Innovation & Member of Management Board (Age 57)
- Dr. Hartmut Klusik, Head of HR, Technology & Sustainability, Labor Director and Member of Management Board (Age 63)
What is Bayer's stock price today?
One share of BAYN stock can currently be purchased for approximately €68.98.
What is Bayer's official website?
How can I contact Bayer?
Bayer's mailing address is Kaiser-Wilhelm-Allee 1, LEVERKUSEN, 51373, Germany. The healthcare company can be reached via phone at +49-214-301.
MarketBeat Community Rating for Bayer (FRA BAYN)
MarketBeat's community ratings are surveys of what our community members think about Bayer and other stocks. Vote "Outperform" if you believe BAYN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BAYN will underperform the S&P 500 over the long term. You may vote once every thirty days.
